Variant report

Variant	nsv892853
Chromosome Location	chr9:26326100-26457404
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Distal block	Cell Line	Cell type
1	chr9:26326443..26327103-chr9:26862889..26863559,2	MCF-7	breast:
2	chr9:25964124..25964728-chr9:26326171..26327079,3	MCF-7	breast:
3	chr9:25963971..25964744-chr9:26326247..26327016,2	MCF-7	breast:

Extended variants
information (count: 1765 )
Associated
traits (count: 119 )

Variant overlapped rSNPs/rCNVs (count:1765 , 50 per page) page: 1 2 3 4 5 6 7 ... 36

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs7864514	chr9:26326100-26326101	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs534949973	chr9:26326107-26326108	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs552872457	chr9:26326130-26326131	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs149021440	chr9:26326186-26326187	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs545241149	chr9:26326187-26326188	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs113303398	chr9:26326217-26326218	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
7	rs557452866	chr9:26326278-26326279	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
8	rs575813468	chr9:26326297-26326298	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
9	rs543039908	chr9:26326331-26326332	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
10	rs561307346	chr9:26326338-26326339	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
11	rs190108957	chr9:26326342-26326343	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
12	rs142067535	chr9:26326396-26326397	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
13	rs111451393	chr9:26326401-26326402	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs548171048	chr9:26326414-26326415	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs532698368	chr9:26326497-26326498	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs1414925	chr9:26326539-26326540	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
17	rs575116805	chr9:26326541-26326542	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs75221433	chr9:26326544-26326545	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs530556168	chr9:26326550-26326551	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs548552148	chr9:26326566-26326567	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs567284560	chr9:26326576-26326577	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs552814582	chr9:26326594-26326595	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs570992852	chr9:26326616-26326617	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs144061023	chr9:26326645-26326646	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs534346189	chr9:26326657-26326658	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs181755732	chr9:26326658-26326659	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs534859939	chr9:26326696-26326697	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs571462559	chr9:26326697-26326698	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs375933552	chr9:26326710-26326711	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs542379201	chr9:26326726-26326727	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs187370756	chr9:26326729-26326730	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs557240964	chr9:26326731-26326732	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs151213421	chr9:26326740-26326741	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs554276182	chr9:26326768-26326769	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs553051864	chr9:26326841-26326842	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs554787821	chr9:26326871-26326872	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs140405766	chr9:26326916-26326917	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs535544736	chr9:26327039-26327040	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs540275749	chr9:26327050-26327051	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs557120774	chr9:26327070-26327071	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs565526471	chr9:26327104-26327105	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs577163126	chr9:26327123-26327124	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs575570908	chr9:26327124-26327125	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs150344557	chr9:26327158-26327159	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs562773395	chr9:26327165-26327166	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs138146228	chr9:26327216-26327217	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs10967311	chr9:26327287-26327288	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
48	rs190544362	chr9:26327359-26327360	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs565154273	chr9:26327374-26327375	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs577135162	chr9:26327379-26327380	Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:119)

Disease	PMID	Source
Breast cancer	16608533	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Glioblastoma multiforme	21080181	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Breast cancer	16272173	CNVD
Medulloblastoma	21979893	CNVD
Hepatocellular carcinoma	16750200	CNVD
Breast cancer	17133270	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Cervical cancer	21063398	CNVD
Retinoblastoma	22278416	CNVD
Splenic marginal zone lymphoma	18492102	CNVD
Melanoma	18172304	CNVD
Biliary cancer	19435499	CNVD
Gastric cancer	21586687	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Myopathy	18421352	CNVD
Neuroblastoma	18664255	CNVD
Acute lymphoblastic leukemia	18957548	CNVD
Myeloproliferative neoplasm	17564968	CNVD
Malignant meningioma	17937814	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	17603634	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Oligodendroglial tumors	17285580	CNVD
Cutaneous squamous cell carcinomas	19131950	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Chordoma	18071362	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Renal cell carcinoma	18592004	CNVD
Developmental delay	19490664	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
microdeletion syndrome	16199537	CNVD
Non-syndromic sensorineural hearing loss	21987784	CNVD
Cancer	20164919	CNVD
Ovarian cancer	21720365	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
small cell lung cancer	20016488	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Lung cancer	18438408	CNVD
Urothelial carcinoma	21177765	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Chronic myeloid leukemia	21384125	CNVD
Breast cancer	21785460	CNVD
Esophageal adenocarcinoma	19417022	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Renal cell carcinoma	21668985	CNVD
Myelodysplastic syndrome	21251322	CNVD
Autism	22495311	CNVD
Hepatocellular carcinoma	18803288	CNVD
Metanephric adenoma	20802469	CNVD
Developmental delay	21147756	CNVD
Pilocytic astrocytoma	18670637	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Melanoma	22183965	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Non-small cell lung cancer	19010865	CNVD
Myoepithelioma	18604193	CNVD
Cancer	22183965	CNVD
Acute myeloid leukemia	19651601	CNVD
Coronary Disease	20032323	CNVD
Squamous cell cancer	20885788	CNVD
Hirschsprung''s Disease	21712996	CNVD
Cancer	21732550	CNVD
Gastric cancer	22539939	CNVD
Cancer	21183584	CNVD
T-cell lymphomas	19863542	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Metastatic melanoma	18483359	CNVD
Non-small cell lung cancer	20864512	CNVD
Cervical cancer	21062161	CNVD
Acute myeloid leukemia	16864856	CNVD
Glioblastoma	17090523	CNVD
Lung cancer	16773561	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Colorectal cancer	16774939	CNVD
Bladder cancer	19088036	CNVD
Colorectal cancer	16272173	CNVD
Melanoma	16977458	CNVD
Glioblastoma multiforme	17369134	CNVD
Chagasic megaesophagus	20163722	CNVD
Melanoma	19566914	CNVD
Squamous cell cancer	19047905	CNVD
Lung adenocarcinoma	19525976	CNVD
Lung cancer	19525976	CNVD
Malignant mesothelioma	18160781	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Hodgkin''s lymphoma	18179710	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Ovarian clear cell carcinoma	21343371	CNVD
Acute myeloid leukemia	21251322	CNVD
Oral cancer	21386901	CNVD
Breast cancer	21858162	CNVD
Pancreatic cancer	21811587	CNVD
Barrett''s syndrome	19417022	CNVD
Myelofibrosis	22110671	CNVD
Urothelial cell carcinoma	18451213	CNVD
polycythaemia	22829968	CNVD
Neuroblastoma	21899760	CNVD
Breast cancer	21364760	CNVD
Schizophrenia	20967226	CNVD
Glioblastoma multiforme	21525872	CNVD
Renal cell carcinoma	21215367	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD

Chromatin state (count:118 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr9:26324200-26327200	Enhancers	Fetal Stomach	stomach
2	chr9:26324400-26326200	Enhancers	Colon Smooth Muscle	Colon
3	chr9:26324400-26326600	Enhancers	HSMM	muscle
4	chr9:26324600-26326600	Enhancers	Muscle Satellite Cultured Cells	--
5	chr9:26324800-26326600	Enhancers	NHDF-Ad	bronchial
6	chr9:26325000-26327200	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
7	chr9:26325200-26326400	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
8	chr9:26325400-26326200	Enhancers	Pancreatic Islets	Pancreatic Islet
9	chr9:26325400-26326400	Weak transcription	Fetal Kidney	kidney
10	chr9:26325400-26326400	Weak transcription	Rectal Smooth Muscle	rectum
11	chr9:26325400-26326400	Weak transcription	HSMMtube	muscle
12	chr9:26325400-26326600	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
13	chr9:26325400-26326600	Enhancers	Fetal Lung	lung
14	chr9:26325400-26327200	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
15	chr9:26325400-26329800	Weak transcription	Ovary	ovary
16	chr9:26325800-26326400	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
17	chr9:26325800-26326600	Enhancers	Brain Hippocampus Middle	brain
18	chr9:26325800-26327000	Enhancers	Hela-S3	cervix
19	chr9:26326200-26326600	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
20	chr9:26326200-26326600	Enhancers	Duodenum Smooth Muscle	Duodenum
21	chr9:26326200-26326600	Flanking Active TSS	Pancreatic Islets	Pancreatic Islet
22	chr9:26326200-26326600	Enhancers	HUVEC	blood vessel
23	chr9:26326400-26326600	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
24	chr9:26326400-26326600	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
25	chr9:26326400-26326600	Enhancers	Adipose Nuclei	Adipose
26	chr9:26326400-26326600	Enhancers	Fetal Kidney	kidney
27	chr9:26326400-26326600	Enhancers	Rectal Smooth Muscle	rectum
28	chr9:26326400-26326600	Enhancers	HSMMtube	muscle
29	chr9:26326600-26331200	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
30	chr9:26329600-26330200	Enhancers	Sigmoid Colon	Sigmoid Colon
31	chr9:26329800-26330200	Enhancers	Pancreas	Pancrea
32	chr9:26329800-26330400	Enhancers	Ovary	ovary
33	chr9:26329800-26331000	Enhancers	Rectal Mucosa Donor 31	rectum
34	chr9:26331000-26331600	Weak transcription	Rectal Mucosa Donor 31	rectum
35	chr9:26331200-26331800	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
36	chr9:26331200-26332000	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
37	chr9:26331600-26331800	Enhancers	Rectal Mucosa Donor 31	rectum
38	chr9:26332600-26332800	Enhancers	Ovary	ovary
39	chr9:26333200-26333400	Enhancers	HUES64 Cell Line	embryonic stem cell
40	chr9:26333400-26333600	Enhancers	iPS-20b Cell Line	embryonic stem cell
41	chr9:26333400-26333800	Enhancers	H9 Cell Line	embryonic stem cell
42	chr9:26333400-26334200	Enhancers	HUES48 Cell Line	embryonic stem cell
43	chr9:26333400-26334200	Enhancers	iPS-15b Cell Line	embryonic stem cell
44	chr9:26333600-26334000	Flanking Active TSS	iPS-20b Cell Line	embryonic stem cell
45	chr9:26334000-26334200	Enhancers	HUES64 Cell Line	embryonic stem cell
46	chr9:26334600-26335200	Enhancers	Fetal Brain Male	brain
47	chr9:26335200-26339800	Weak transcription	Fetal Brain Male	brain
48	chr9:26339800-26340200	Enhancers	Fetal Brain Male	brain
49	chr9:26350000-26351600	ZNF genes & repeats	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
50	chr9:26355800-26356200	Enhancers	Fetal Brain Female	brain

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links